Business Context and Reporting Period
This Form 8-K filing by Indaptus Therapeutics, Inc. (INDP) reports a material corporate action dated June 25, 2025. The Company, incorporated in Delaware and trading on the Nasdaq Capital Market, announced the implementation of a reverse stock split approved by its stockholders at the Annual Meeting on June 10, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structural amendment to the Company's capitalization.
Material Changes
- Reverse Stock Split: The Board approved a 1-for-28 reverse stock split of issued and outstanding common stock.
- Effective Date: The split became effective at 5:00 p.m. Eastern Time on June 26, 2025, following the filing of a Certificate of Amendment with the Delaware Secretary of State.
- Trading Resumption: Common stock began trading on a split-adjusted basis on June 27, 2025, under the symbol "INDP."
- Fractional Shares: No fractional shares were issued; holders received cash payments in lieu of fractional shares based on the closing price on June 26, 2025.
- Adjustments: Per share exercise prices and share counts for outstanding options and warrants were proportionately adjusted.
- Identification: The new CUSIP number for the common stock is 45339J 204.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard implications of a reverse stock split. The primary purpose of the filing is to disclose the amendment to the Articles of Incorporation and the change in the rights of security holders regarding share count and price.
Investor Verification Checklist
- Verify the new CUSIP number (45339J 204) for trading and settlement purposes.
- Confirm the adjusted share count and exercise prices for any held options or warrants.
- Check for cash payments received in lieu of fractional shares if the pre-split holding was not divisible by 28.
- Review the Company's stock price performance on the Nasdaq Capital Market starting June 27, 2025, on a split-adjusted basis.